1-7 of 7
Jenny Rinke
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Combination of Asciminib with ATP Competing Tyrosine Kinase Inhibitors Might Overcome the Negative Impact of ASXL1 Mutations on Molecular Response in Newly Diagnosed CML Patients

Thomas Ernst, Jenny Rinke, Philipp le Coutre, Martina Crysandt, Tim H. H. Brummendorf, Andreas Burchert, Fabian Lang, Susanne Saussele, Markus Pfirrmann, Thomas Lang, Christian Fabisch, Andreas Hochhaus
Journal: Blood
Blood (2024) 144 (Supplement 1): 1774.
https://doi.org/10.1182/blood-2024-193991
Published: 2024
Journal Articles

Treatment Free Remission after Nilotinib Plus Peg-Interferon Alpha Induction and Peg-Interferon Alpha Maintenance Therapy for Newly Diagnosed Chronic Myeloid Leukemia Patients; The Tiger Trial

Andreas Hochhaus, Andreas Burchert, Susanne Saussele, Gabriela M Baerlocher, Jiří Mayer, Tim H. Brümmendorf, Paul La Rosée, Dominik Heim, Stefan W. Krause, Philipp le Coutre, Jenny Rinke, Thoralf Lange, Alice Fabarius, Marcel Lorch, Mathias Hanel, Frank Stegelmann, Georg-Nikolaus Franke, Markus P. Radsak, Volker Kunzmann, Daniela Zackova, Danny Himsel, Denise Kohn, Thomas Lang, Rüdiger Hehlmann, Christian Fabisch, Thomas Ernst, Markus Pfirrmann
Journal: Blood
Blood (2023) 142 (Supplement 1): 446.
https://doi.org/10.1182/blood-2023-182792
Published: 2023
Journal Articles

ASXL1 Mutations Predict Inferior Molecular Response to Nilotinib Treatment in Newly Diagnosed Patients with Chronic Myeloid Leukemia in Chronic Phase

Thomas Ernst, Lioba Schönfeld, Jenny Rinke, Anna Hinze, Saskia N. Nagel, Vivien Schäfer, Thomas Schenk, Christian Fabisch, Tim H. Brümmendorf, Andreas Burchert, Philipp le Coutre, Stefan W. Krause, Susanne Saussele, Fatemeh Safizadeh, Markus Pfirrmann, Andreas Hochhaus
Journal: Blood
Blood (2022) 140 (Supplement 1): 807–808.
https://doi.org/10.1182/blood-2022-165041
Published: 2022
Journal Articles

Prevalence and Dynamics of Clonal Hematopoiesis Caused By Leukemia Associated Mutations in Elderly Individuals without Hematologic Disorders

Thomas Ernst, MD, Jenny Rinke, Danica Midic, Violetta Müller, Anja Waldau, Alexander Kaiser, MD, Bernd Gruhn, Jürgen Landschulze, MD, Frank Pester, MD, Andreas Hochhaus, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1141.
https://doi.org/10.1182/blood.V130.Suppl_1.1141.1141
Published: 2017
Journal Articles

Prevalence and Dynamics of BCR-ABL Independent Gene Mutations in Patients with Chronic Myeloid Leukemia

Thomas Ernst, MD, Jenny Rinke, Melinda Busch, Jana Ernst, MD, Ellen Obstfelder, Mathias Schmidt, MD, Vivien Schäfer, Anja Waldau, Nils Winkelmann, MD, Bernd Gruhn, MD, Andreas Hochhaus, MD
Journal: Blood
Blood (2016) 128 (22): 1221.
https://doi.org/10.1182/blood.V128.22.1221.1221
Published: 2016
Journal Articles

Molecularly Defined Clonal Evolution in Patients with Chronic Myeloid Leukemia Independent of the BCR-ABL Status

Thomas Ernst, MD, Mathias Schmidt, Jenny Rinke, Vivien Schäfer, Anja Waldau, Ellen Obstfelder, Nils Winkelmann, MD, Janine Ziermann, PhD, Susanne Schnittger, PhD, Torsten Haferlach, MD PhD, Claudia Haferlach, MD, Andreas Hochhaus, MD
Journal: Blood
Blood (2014) 124 (21): 4513.
https://doi.org/10.1182/blood.V124.21.4513.4513
Published: 2014
Journal Articles

Frequency and Clinical Presentation of Polycomb Repressive Complex 2 (PRC2) Component Mutations in Childhood Acute Lymphoblastic Leukemia

Thomas Ernst, MD, Vivien Schäfer, Jenny Rinke, Anja Waldau, Susan Wittig, Jana Ernst, MD, Ralf Häfer, PhD, James F Beck, MD, Andreas Hochhaus, MD, Bernd Gruhn, MD
Journal: Blood
Blood (2012) 120 (21): 1474.
https://doi.org/10.1182/blood.V120.21.1474.1474
Published: 2012